Sentence examples for the patentability from inspiring English sources

But while it streamlines patent and trademark procedures, raises the standards on patent eligibility, and improves trademark and copyright enforcement, it does not deal with what IP legal expert Luigi Palombi calls "the elephant in the room"—the patentability of genetic material.

More specifically, we analyzed the users' demographics, geographic locations, and attitudes toward the CHEO position on gene patents and the patentability of human genes in principle.

Indeed, Rosenfeld and Mason [ 1] rely on their results to propose that 'the Supreme Court and Congress should limit the patenting of existing nucleotide sequences because of their broad scope and non-specificity in the human genome.' We note that none of the above necessarily reflects on the position of the authors [ 1] in the ongoing debate regarding the patentability of 'gene patents'.

The USPTO is still considering whether to reexamine the patentability of Versata's '350 patent in a separate ex-parte reexamination proceeding based on prior art, notes  Arner.

For US patentability purposes, only an oral disclosure that takes place in the US will factor into the patentability decision for a US patent.

After that, you will have to carry out the patentability analysis by well qualified patent analyst who has background of same technology and works in a quality patent service provider.

Some of these policies include: (1) reinforcing the research exemption for academic researchers, (2) raising the "bar" for the criteria of patentability, (3) restricting the scope of patents, (4) disclosing conflicts of interest related to DNA patents, (5) sharing the economic benefits of patenting with patients, and (6) providing insurance coverage for some types of genetic tests.

Basically, the court just said it would rule on this particular patent and not make any real statements on the overall patentability of business methods or software.

How does the operation of intellectual property rights involving genetics and genomics subject matter differ in the United States from other countries (e.g., what are the differences in the criteria for patentability applied in the U.S. and by other major patent offices, such as in Europe and Japan)?

They can and have been granted intensively on biological material in accordance with the national patentability requirements where protection is sought, mostly in developed countries and in particular the USA.

This article proposes three responses: to raise the standards for patentability, to decrease the use of patents to bar research, and to ease legal attack on patents of questionable validity (Science 17 March 2000, p. 1933).